Collegium Pharmaceutical (COLL) Interest Coverage Ratio (2015 - 2026)
Collegium Pharmaceutical (COLL) recorded quarterly Interest Coverage Ratio of 1.95 in Q1 2026, down 38.15% quarter-over-quarter from 3.15 in Q4 2025, and up 86.72% on a YoY basis from 1.04 in Q1 2025.
Collegium Pharmaceutical (COLL) Interest Coverage Ratio (2015 - 2026) Analysis & Trends
Collegium Pharmaceutical's Interest Coverage Ratio history runs 11 years deep, the most recent figure standing at 1.95 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 86.72% year-over-year to 1.95; the TTM figure through Mar 2026 stood at 2.44 (up 32.96% YoY), while the FY2025 annual figure was 2.18, down 4.98% from the prior year.
- Interest Coverage Ratio was 1.95 for Q1 2026 at Collegium Pharmaceutical, down from 3.15 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 3.2 in Q4 2023 to a low of 1.72 in Q1 2022.
- Historically, Interest Coverage Ratio has averaged 1.7 across 5 years, with a median of 1.72 in 2025.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio slumped 146.37% in 2022, then soared 459.91% in 2023.
- A 5-year view of Interest Coverage Ratio shows it stood at 0.57 in 2022, then jumped by 459.91% to 3.2 in 2023, then sank by 47.42% to 1.68 in 2024, then soared by 87.2% to 3.15 in 2025, then slumped by 38.15% to 1.95 in 2026.
- The last three Interest Coverage Ratio figures came in at 1.95 (Q1 2026), 3.15 (Q4 2025), and 2.85 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Collegium Pharmaceutical | 1.10 Bn | 813.71 Mn | 117.25 Mn | 1.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.95 |
| Dec 31, 2025 | 3.15 |
| Sep 30, 2025 | 2.85 |
| Jun 30, 2025 | 1.72 |
| Mar 31, 2025 | 1.04 |
| Dec 31, 2024 | 1.68 |
| Sep 30, 2024 | 1.89 |
| Jun 30, 2024 | 3.05 |
| Mar 31, 2024 | 2.85 |
| Dec 31, 2023 | 3.20 |
| Sep 30, 2023 | 2.17 |
| Jun 30, 2023 | 1.63 |
| Mar 31, 2023 | 1.15 |
| Dec 31, 2022 | 0.57 |
| Sep 30, 2022 | 1.07 |
| Jun 30, 2022 | 0.63 |
| Mar 31, 2022 | -1.72 |
| Dec 31, 2021 | -7.17 |
| Sep 30, 2021 | 2.77 |
| Jun 30, 2021 | 3.03 |